Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Győző, Dani"'
Publikováno v:
Cardiologia Hungarica. 50:246-251
Publikováno v:
Cardiologia Hungarica. 50:29-34
Autor:
Győző Dani, Zoltán Jambrik, László Márk, Mária Nagy, Csaba Baranyai, András Katona, Marianna Borbély
Publikováno v:
Orvosi Hetilap. 159:478-484
Abstract: Introduction: The actual guidelines of cardiovascular prevention lay special emphasis on the lipid-lowering therapy of patients suffering from acute coronary syndrome (ACS). Aim: To evaluate the occurrence of high-intensity statin therapy,
Autor:
Erzsébet Nagy, Robert Vendrey, Zoltán Jambrik, András Katona, Csaba Baranyai, Győző Dani, György Sziklai, László Márk
Publikováno v:
Cardiologia Hungarica. 47:329-335
Autor:
Győző Dani, László Márk
Publikováno v:
Orvosi Hetilap. 157:746-752
The incidence and the public health importance of diabetes mellitus are growing continuously. Despite the improvement observed in the latest years, the leading cause of morbidity and mortality of diabetics are cardiovascular diseases. The diagnosis o
Autor:
László, Márk, Mária, Nagy, Győző, Dani, Csaba, Baranyai, Marianna, Borbély, András, Katona, Zoltán, Jambrik
Publikováno v:
Orvosi hetilap. 159(12)
The actual guidelines of cardiovascular prevention lay special emphasis on the lipid-lowering therapy of patients suffering from acute coronary syndrome (ACS).To evaluate the occurrence of high-intensity statin therapy, recommended by guidelines, at
Autor:
László, Márk, Győző, Dani
Publikováno v:
Orvosi hetilap. 157(19)
The incidence and the public health importance of diabetes mellitus are growing continuously. Despite the improvement observed in recent years, the leading cause of morbidity and mortality of diabetics are cardiovascular diseases. The diagnosis of di
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Background Vitamin K antagonists, despite their tight therapeutic spectrum and the fear of bleeding complications, were long the most important drugs used in anticoagulant therapy. The aim of this study was to evaluate the quality of anticoagulant th
Publikováno v:
Orvosi hetilap. 149(37)
One of the greatest challenges of cardiovascular prevention is to minimize the risk of cardiovascular events through the achievement of target lipid levels. Its importance is suggested by the comprehensive meta-analyses of large scale clinical trials
Publikováno v:
Central European journal of public health. 14(1)
SummAry Objective: The patients after myocardial infarction could hope for a significant improvement in their life expectancy when complying with the principles of the secondary prevention. Today there is no doubt that the administration of ACE-inhib